Tag: RAMSES

Paliforzia (AR101)

Aimmune Issues Update on AR101 Peanut Oral Immunotherapy Candidate

The company announces their timeline for continued progress toward an FDA approved standardized therapy.
Paliforzia (AR101)

Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut...

First of 440 patients enrolled in study of AR101.